Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» gene editing
gene editing
Gene editing biotech Beam adds to drug delivery stable with $120M GuideTx buy
Fierce Biotech
Tue, 02/23/21 - 10:51 am
Beam Therapeutics
gene editing
drug delivery
Precision's one-time gene editing treatment lowers cholesterol in monkeys for 3 years
Fierce Biotech
Fri, 02/19/21 - 10:30 am
Precision Biosciences
gene therapy
gene editing
familial hypercholesterolemia
Ensoma debuts with $70M, Takeda deal to pursue off-the-shelf genomic medicines
Fierce Biotech
Thu, 02/11/21 - 10:37 am
Ensoma
Takeda
CRISPR
gene editing
genomic medicine
After ditching Editas, AbbVie taps Caribou for new CRISPR, CAR-T pact
Fierce Biotech
Wed, 02/10/21 - 10:27 am
AbbVie
Editas Medicine
CRISPR
Caribou Biosciences
gene editing
Beam, Verve stockpile cash as investors bank on gene editing progress
BioPharma Dive
Tue, 01/19/21 - 09:13 pm
Beam Therapeutics
Verve Therapeutics
gene editing
funding
Bold Predictions for Medtech in 2021
Medical Devices and Diagnostics Industry
Thu, 01/14/21 - 10:32 am
devices
Medtech
COVID-19
remote patient monitoring
telemedicine
home care
digital medicine
artificial intelligence
machine learning
robotic surgery
3D printing
Joe Biden
gene editing
microbiome
CAR-T
Takeda’s gene editing partner is snapped up for $250M cash as sector continues to heat up
Endpoints
Tue, 12/15/20 - 08:22 pm
Takeda
gene editing
Japan
AnGes
EmendoBio
1st Patients To Get CRISPR Gene-Editing Treatment Continue To Thrive
NPR
Tue, 12/15/20 - 10:32 am
CRISPR
gene editing
sickle cell disease
Bayer powers gene-editing startup Metagenomi to $65M A round
Fierce Biotech
Thu, 11/12/20 - 10:55 am
Metagenomi
Bayer
CRISPR
gene therapy
gene editing
Intellia, beginning treatment in CRISPR study, secures Gates Foundation backing
BioPharma Dive
Wed, 11/11/20 - 11:03 pm
Intellia Therapeutics
CRISPR
gene editing
Gates Foundation
EdiGene raises $67M to take gene-editing therapies into humans
Fierce Biotech
Tue, 10/13/20 - 11:09 am
EdiGene
gene editing
CAR-T
beta thalassemia
ET-01
ET-02
Jennifer Doudna’s New Gene Editing Company Launches With A $20 Million Round To Develop Genetic Medicines
Forbes
Tue, 10/6/20 - 11:16 pm
Jennifer Doudna
gene editing
Scribe Therapeutics
ALS
Moderna lands $100M upfront in deals with Vertex, Chiesi
Fierce Biotech
Thu, 09/17/20 - 10:44 am
Moderna Therapeutics
cystic fibrosis
R&D
Vertex Pharmaceuticals
gene editing
Chiesi
Mammoth Biosciences Signs Exclusive Deal For Recently-Discovered Crispr Protein
Forbes
Thu, 08/13/20 - 09:57 am
Mammoth Biosciences
gene editing
CRISPR
University of California Berkeley
AbbVie cuts Editas CRISPR pact it inherited from Allergan
Fierce Biotech
Fri, 08/7/20 - 10:52 am
Editas Medicine
Allergan
AbbVie
gene editing
CRISPR
CRISPR and Vertex show durability of gene-editing therapy, hoping for one and done treatment
Fierce Biotech
Mon, 06/15/20 - 10:35 am
Vertex Pharmaceuticals
CRISPR Therapeutics
CTX001
gene editing
sickle cell disease
beta thalassemia
Verve Therapeutics Adds $63M to Edit Heart Attack Risk Out of Genes
Xconomy
Thu, 06/11/20 - 11:17 am
gene editing
Verve Therapeutics
heart attacks
familial hypercholesterolemia
Stanford team deploys CRISPR gene editing to fight COVID-19
Fierce Biotech
Fri, 06/5/20 - 10:35 am
Stanford University
CRISPR
gene editing
pandemic
COVID-19
Viacyte Adds $27M to Move Ahead Trio of Stem Cell Diabetes Treatments
Xconomy
Tue, 05/26/20 - 11:52 am
ViaCyte
diabetes
gene editing
stem cells
Here's Why Editas Could Beat Intellia to a CRISPR Therapy
Motley Fool
Fri, 05/22/20 - 10:30 am
gene editing
CRISPR
Editas Medicine
Intellia
earnings
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
next ›
last »